Rv1218c, an ABC transporter of Mycobacterium tuberculosis with implications in drug discovery
about
Crystal structure of the transcriptional regulator Rv1219c ofMycobacterium tuberculosisGlobal transcriptional profiling of longitudinal clinical isolates of Mycobacterium tuberculosis exhibiting rapid accumulation of drug resistanceEfflux pump gene expression in multidrug-resistant Mycobacterium tuberculosis clinical isolatesNovel inhibitors of cholesterol degradation in Mycobacterium tuberculosis reveal how the bacterium's metabolism is constrained by the intracellular environmentGenome Analysis of the First Extensively Drug-Resistant (XDR) Mycobacterium tuberculosis in Malaysia Provides Insights into the Genetic Basis of Its Biology and Drug ResistanceIdentification of novel leads applying in silico studies for Mycobacterium multidrug resistant (MMR) protein.New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in MycobacteriaInterplay between Mutations and Efflux in Drug Resistant Clinical Isolates of Mycobacterium tuberculosisGenome-wide transcription analyses in Mycobacterium tuberculosis treated with lupulone.Verapamil, and its metabolite norverapamil, inhibit macrophage-induced, bacterial efflux pump-mediated tolerance to multiple anti-tubercular drugs.The genome of Mycobacterium africanum West African 2 reveals a lineage-specific locus and genome erosion common to the M. tuberculosis complexThe role of transport mechanisms in mycobacterium tuberculosis drug resistance and tolerance.Antimicrobial efflux pumps and Mycobacterium tuberculosis drug tolerance: evolutionary considerations.Energy metabolism and drug efflux in Mycobacterium tuberculosisAntimicrobial treatment improves mycobacterial survival in nonpermissive growth conditions.Inhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugs.The expression of ABC efflux pump, Rv1217c-Rv1218c, and its association with multidrug resistance of Mycobacterium tuberculosis in China.Involvement of efflux pumps in the resistance to peptidoglycan synthesis inhibitors in Mycobacterium tuberculosisNitroarenes as Antitubercular Agents: Stereoelectronic Modulation to Mitigate Mutagenicity.Antimycobacterial activity of five efflux pump inhibitors against Mycobacterium tuberculosis clinical isolates.Docking analysis insights quercetin can be a non-antibiotic adjuvant by inhibiting Mmr drug efflux pump in Mycobacterium sp. and its homologue EmrE in Escherichia coli.Efflux pumps of Mycobacterium tuberculosis play a significant role in antituberculosis activity of potential drug candidates.NapM, a new nucleoid-associated protein, broadly regulates gene expression and affects mycobacterial resistance to anti-tuberculosis drugs.Efflux Pumps in Mycobacteria: Antimicrobial Resistance, Physiological Functions, and Role in PathogenicityMeasuring Efflux and Permeability in Mycobacteria
P2860
Q27681336-75F4C3CD-6664-4120-A23A-0DFD650A8918Q28485244-E2832FD9-75C0-429D-931D-5B11B8B13F0BQ28543543-B41689EF-CA02-471B-B622-ABA9347ACC9BQ28543551-BAC47D8B-151D-4D71-84A0-24A7BF7A5D7CQ28545741-A63E412D-643C-4813-A1D9-AC4CC8186B96Q31141792-07FB6997-7506-41EF-AAEA-563DCCBE9E27Q33600161-8AEA80AA-D68C-4538-B5D2-8642AD77AF6FQ33607162-D964DE85-0CE9-45F2-BD3D-47188677F627Q33761987-16BC7907-70D9-4BDC-8F20-66BB918D509BQ33947806-E8B156F6-4BF6-422E-A620-2CEECD04E010Q35788113-8471DC5A-1604-46A3-8CF8-78BF60121DC8Q37277325-9216A305-79BB-4CA5-862C-A6112956FB50Q37385024-CFC7995C-D03A-4ADD-8B90-EE6EA1703213Q37712986-F9A1BCA9-7585-4DB5-AB15-478249989C52Q37713046-5C6AF880-99F8-4234-BCD1-AB3E5B913EE0Q38056146-819C389C-D022-4A50-9AC3-BA2031DE967CQ39521856-3CB6D296-E713-4C35-ABA2-BB9A5AC407F1Q39765849-9200CA40-D2D0-4FCC-9F00-1FEF7B032153Q40838217-7649B1C9-FB09-48DD-AAED-5D6E9716DD7FQ40954185-3BEB55C9-1874-4C7F-814C-887547DC1F63Q41710215-3A60D0F0-DE20-4639-A001-E274B19B455AQ42151604-140A793E-8752-4A6C-B7D7-710C934FF688Q53792036-81B50329-A439-4477-8A69-2D712B726641Q57656351-03F305C3-4EB8-4CB8-8927-FAE900DFA95AQ57656378-39EF9838-93A5-4DC2-A3DA-5CA6EA5EB0B7
P2860
Rv1218c, an ABC transporter of Mycobacterium tuberculosis with implications in drug discovery
description
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2010
@ast
im Dezember 2010 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2010/12/01)
@sk
vědecký článek publikovaný v roce 2010
@cs
wetenschappelijk artikel (gepubliceerd op 2010/12/01)
@nl
наукова стаття, опублікована в грудні 2010
@uk
مقالة علمية (نشرت في ديسمبر 2010)
@ar
name
Rv1218c, an ABC transporter of ...... implications in drug discovery
@ast
Rv1218c, an ABC transporter of ...... implications in drug discovery
@en
Rv1218c, an ABC transporter of ...... implications in drug discovery
@nl
type
label
Rv1218c, an ABC transporter of ...... implications in drug discovery
@ast
Rv1218c, an ABC transporter of ...... implications in drug discovery
@en
Rv1218c, an ABC transporter of ...... implications in drug discovery
@nl
prefLabel
Rv1218c, an ABC transporter of ...... implications in drug discovery
@ast
Rv1218c, an ABC transporter of ...... implications in drug discovery
@en
Rv1218c, an ABC transporter of ...... implications in drug discovery
@nl
P2093
P2860
P921
P356
P1476
Rv1218c, an ABC transporter of ...... implications in drug discovery
@en
P2093
Meenakshi Balganesh
Nimi Marcel
Sanjana Kuruppath
Sreevalli Sharma
Umender Sharma
P2860
P304
P356
10.1128/AAC.00610-10
P407
P577
2010-12-01T00:00:00Z